Life Science

A trypsin-like protease inhibitor known to inhibit trypsin and various inflammatory proteases including plasmin, kallikrein, and thrombin used in the treatment of chronic pancreatitis and various manifestations of fibrosis.

A trypsin-like protease inhibitor known to inhibit trypsin and various inflammatory proteases including plasmin, kallikrein, and thrombin used in the treatment of chronic pancreatitis and various manifestations of fibrosis.

A trypsin-like protease inhibitor known to inhibit trypsin and various inflammatory proteases including plasmin, kallikrein, and thrombin used in the treatment of chronic pancreatitis and various manifestations of fibrosis.

&nbsp Kit Description GenScript cAMP ELISA Detection Kit is a competition enzyme-linked immunoassay which can be used for quantitative detection of cAMP (Adenosine 3&#39,5&#39-cyclic monophosphate) in samples such as serum, plasma, saliva, cell

cAMP-peroxidase conjugate is a product most suitable for GenScript's THE &trade Anti cAMP monoclonal antibody (Cat. No.

A cytotoxic, quinoline alkaloid that inhibits the DNA enzyme topoisomerase I (Top I) by binding the Top1-DNA cleavage complex and inducing DNA-strand breaks has strong anti-tumor activity and induces DNA damage at concentrations as low as 51 nM in

A cytotoxic, quinoline alkaloid that inhibits the DNA enzyme topoisomerase I (Top I) by binding the Top1-DNA cleavage complex and inducing DNA-strand breaks has strong anti-tumor activity and induces DNA damage at concentrations as low as 51 nM in

A cytotoxic, quinoline alkaloid that inhibits the DNA enzyme topoisomerase I (Top I) by binding the Top1-DNA cleavage complex and inducing DNA-strand breaks has strong anti-tumor activity and induces DNA damage at concentrations as low as 51 nM in

A cytotoxic, quinoline alkaloid that inhibits the DNA enzyme topoisomerase I (Top I) by binding the Top1-DNA cleavage complex and inducing DNA-strand breaks has strong anti-tumor activity and induces DNA damage at concentrations as low as 51 nM in

A prodrug of the potent, long-acting, and selective AT1 receptor antagonist, candesartan 4-16 mg/day effectively reduces diastolic blood pressure and has proved useful in the treatment of hypertension and diabetes.

A prodrug of the potent, long-acting, and selective AT1 receptor antagonist, candesartan 4-16 mg/day effectively reduces diastolic blood pressure and has proved useful in the treatment of hypertension and diabetes.

A prodrug of the potent, long-acting, and selective AT1 receptor antagonist, candesartan 4-16 mg/day effectively reduces diastolic blood pressure and has proved useful in the treatment of hypertension and diabetes.